ZIP transporters‐regulated Zn 2+ homeostasis: A novel determinant of human diseases
Journal of Cellular Physiology · 2024-05 · 239 (5)
DOI: 10.1002/jcp.31223 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular Physiology, online erschienen am 26.03.2024. Verfasst von Huimei Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Hengyang Medical School, University of South China, Hengyang, China. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Cation Transport Proteins, Neoplasms, Zinc. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 159 Literaturangaben. Gefördert von: Hunan Provincial Natural Science Foundation of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
As an essential trace element for organisms, zinc participates in various physiological processes, such as RNA transcription, DNA replication, cell proliferation, and cell differentiation. The destruction of zinc homeostasis is associated with various diseases. Zinc homeostasis is controlled by the cooperative action of zinc transporter proteins that are responsible for the influx and efflux of zinc. Zinc transporter proteins are mainly categorized into two families: Zrt/Irt‐like protein ( SLC39A /ZIP) family and zinc transporter ( SLC30A /ZNT) family. ZIP transporters contain 14 members, namely ZIP1‐14, which can be further divided into four subfamilies. Currently, ZIP transporters‐regulated zinc homeostasis is one of the research hotspots. Cumulative evidence suggests that ZIP transporters‐regulated zinc homeostasis may cause physiological dysfunction and contribute to the onset and progression of diverse diseases, such as cancers, neurological diseases, and cardiovascular diseases. In this review, we initially discuss the structure and distribution of ZIP transporters. Furthermore, we comprehensively review the latest research progress of ZIP transporters‐regulated zinc homeostasis in diseases, providing a new perspective into new therapeutic targets for treating related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Hengyang Medical School, University of South China, Hengyang, China.
- Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang, China.
ORCID-Profile: Lanfang Li
Förderung
- Hunan Provincial Natural Science Foundation of China
- National Natural Science Foundation of China
Zitieren
APA
Liu, H., Li, L., & Lu, R. (2024). ZIP transporters‐regulated Zn 2+ homeostasis: A novel determinant of human diseases. Journal of Cellular Physiology, 239(5). https://doi.org/10.1002/jcp.31223
Vancouver
Liu H, Li L, Lu R. ZIP transporters‐regulated Zn 2+ homeostasis: A novel determinant of human diseases. Journal of Cellular Physiology. 2024;239(5). doi:10.1002/jcp.31223
BibTeX
@article{Liu2024,
author = {Liu, Huimei and Li, Lanfang and Lu, Ruirui},
title = {ZIP transporters‐regulated Zn 2+ homeostasis: A novel determinant of human diseases},
journal = {Journal of Cellular Physiology},
year = {2024},
volume = {239},
number = {5},
doi = {10.1002/jcp.31223}
}
EUVIMED